Mrv1909 12051923432D 10 11 0 0 0 0 999 V2000 -0.6654 1.4935 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.8298 0.5072 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.6654 -0.9819 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.8298 -0.8207 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.3800 0.2557 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.0490 0.2557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0490 -0.5693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.6654 0.6683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.3114 -0.1567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.3800 -0.5693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 8 2 0 0 0 0 2 6 1 0 0 0 0 2 9 1 0 0 0 0 3 7 1 0 0 0 0 3 10 1 0 0 0 0 4 7 1 0 0 0 0 4 9 2 0 0 0 0 5 8 1 0 0 0 0 5 10 2 0 0 0 0 6 7 2 0 0 0 0 6 8 1 0 0 0 0 M END > DB04076 > drugbank > O=C1N=CNC2=C1NC=N2 > InChI=1S/C5H4N4O/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10) > FDGQSTZJBFJUBT-UHFFFAOYSA-N > C5H4N4O > 136.1115 > 136.03851077 > 4 > 14 > 11.782205311148328 > 1 > 2 > 0 > 0 > 6,7-dihydro-3H-purin-6-one > -0.74 > -0.3616587753333333 > -1.79 > 0 > 2 > 0 > 12.873385784880627 > 9.409939285794493 > 2.284234192567251 > 70.14 > 35.611799999999995 > 0 > 1 > 2.20e+00 g/l > N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-nitro-5-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzamide > 0 > DB04076 > EXPT01767 > experimental > Hypoxanthine $$$$